28181464|t|Physicochemical characterization of chitosan - hyaluronan -coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells
28181464|a|To investigate the potential of modified solid lipid nanoparticles (SLN) for the delivery of paclitaxel (PAX). SLN loaded with PAX were prepared via modified high-pressure hot homogenization. Formulation parameters were optimized to obtain a high-quality delivery system. SLN cores were coated, layer-by-layer, with a chitosan and hyaluronan (HA) shell. Selectivity toward HA receptors was tested in a breast cancer cell line, MCF-7. Stable and reproducible nano-sized and negatively charged nanoparticles resulted. Findings reveal that chitosan - HA -coated SLN facilitated the targeting, cellular uptake and the time-/dose-controlled delivery and release of PAX, enhancing intrinsic chemotherapeutic activities. SLN are suitable carrier candidates for nano-oncology given their localized, and potent cytotoxic potential overcoming multidrug-resistant cancer cells.
28181464	36	44	chitosan	T103	UMLS:C0162969
28181464	47	57	hyaluronan	T103	UMLS:C0813622
28181464	72	91	lipid nanoparticles	T074	UMLS:C1709148
28181464	109	117	delivery	T058	UMLS:C0565867
28181464	121	131	paclitaxel	T103	UMLS:C0144576
28181464	135	157	proof-of-concept study	T062	UMLS:C2603343
28181464	161	180	breast cancer cells	T017	UMLS:C1512505
28181464	222	247	solid lipid nanoparticles	T074	UMLS:C1709148
28181464	249	252	SLN	T074	UMLS:C1709148
28181464	274	284	paclitaxel	T103	UMLS:C0144576
28181464	286	289	PAX	T103	UMLS:C0144576
28181464	292	311	SLN loaded with PAX	T103	UMLS:C3898158
28181464	339	371	high-pressure hot homogenization	T058	UMLS:C3828864
28181464	373	395	Formulation parameters	T062	UMLS:C0524527
28181464	423	451	high-quality delivery system	T074	UMLS:C0085104
28181464	453	456	SLN	T074	UMLS:C1709148
28181464	499	507	chitosan	T103	UMLS:C0162969
28181464	512	522	hyaluronan	T103	UMLS:C0813622
28181464	524	526	HA	T103	UMLS:C0813622
28181464	554	556	HA	T103	UMLS:C0813622
28181464	557	566	receptors	T103	UMLS:C0597357
28181464	583	606	breast cancer cell line	T017	UMLS:C1512505
28181464	608	613	MCF-7	T017	UMLS:C0596890
28181464	718	726	chitosan	T103	UMLS:C0162969
28181464	729	731	HA	T103	UMLS:C0813622
28181464	740	743	SLN	T074	UMLS:C1709148
28181464	771	786	cellular uptake	T038	UMLS:C3888108
28181464	841	844	PAX	T103	UMLS:C0144576
28181464	895	898	SLN	T074	UMLS:C1709148
28181464	912	930	carrier candidates	T074	UMLS:C1706209
28181464	935	948	nano-oncology	T091	UMLS:C0278627
28181464	983	1002	cytotoxic potential	T103	UMLS:C0304497
28181464	1003	1013	overcoming	T033	UMLS:C0243095
28181464	1014	1046	multidrug-resistant cancer cells	T038	UMLS:C0282588